DuPont Q4 GAAP loss $(0.27)/share but adj. EPS $0.46 beats; initiates FY2026 guide

DuPont de Nemours, Inc.

2025-FY EPS reported -$1.86 revenue$6,849,000,000

Q4 net sales $1.7B flat, organic -1%; GAAP loss from cont. ops $(108)M vs. $(291)M year ago.
Q4 operating EBITDA $409M (+4%); adjusted EPS $0.46 (+18% YoY) vs. guidance of $0.39.
FY 2026 net sales guided to $7.075-7.135B, adjusted EPS $2.25-2.30, operating EBITDA $1.725-1.755B.
Healthcare & Water Technologies full-year sales +9% (org +7%); margin 30.1% (+170 bps).
Diversified Industrials full-year net sales -3% (org -2%) on construction weakness; margin 22.1%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.